Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Neurological Sciences
Published in: Neurological Sciences 3/2011

01-06-2011 | Original Article

Quality of life in multiple sclerosis patients with urinary disorders: reliability and validity of the Turkish version of King’s Health Questionnaire

Authors: Yeşim Akkoc, Hale Karapolat, Sibel Eyigor, Hilal Yesil, Nur Yüceyar

Published in: Neurological Sciences | Issue 3/2011

Login to get access

Abstract

MS patients frequently present with urinary system symptoms, which have a negative effect on the quality life. The aim of our study was to demonstrate the validity and reliability of the Turkish King’s Health Questionnaire (KHQ) in MS patients. The study included 37 patients. For analysis of test–retest reliability, the Turkish version of the KHQ developed and the “translation-back translation” method was performed. To assess the validity of these results, Multiple Sclerosis Quality of Life Scale (MQoL-54) and Expanded Disability Status Scale (EDSS) were used. The internal consistency (intra-class correlation coefficient: 0.59–0.94) and test–retest reliability (Cronbach’s α-score 0.59–0.94) of KHQ were found to be high (p < 0.05). A significant correlation was detected between most of the KHQ subscores and the physical and mental MQoL-54 and EDSS (total and bowel/bladder, p < 0.05) subscores. The KHQ may be used to determine the effect of incontinence on the quality of life for MS patients.

Literature
  1. Borello-France D, Leng W, O’Leary M, Xavier M, Erickson J, Chancellor MB, Cannon TW (2004) Bladder and sexual function among women with multiple sclerosis. Mult Scler 10:455–461PubMedView Article
  2. Nicholas RS, Friede T, Hollis S, Young CA (2009) Anticholinergics for urinary symptoms in multiple sclerosis. Cochrane Database Syst Rev 1:CD004193
  3. Del Popolo G, Panariello G, Del Corso F, De Scisciolo G, Lombardi G (2008) Diagnosis and therapy for neurogenic bladder dysfunctions in multiple sclerosis patients. Neurol Sci 29:S352–S355PubMedView Article
  4. Krane RJ, Siroky MB (1979) Classification of neuro-urologic disorders.In: Krane RJ, Siroky MB (eds) Clinical neuro-urology. Little Brown, Boston, pp 143–158
  5. Abrams P, Kelleher CJ, Kerr LA, Rogers RG (2000) Overactive bladder significantly affects quality of life. Am J Manag Care 6:S580–S590PubMed
  6. Thom DH (2000) Overactive bladder: epidemiology and impact on quality of life. Patients Care Winter Suppl 6–14
  7. Miller YD, Brown WJ, Smith N, Chiarelli P (2003) Managing urinary incontinence across the lifespan. Int J Behav Med 10:143–161PubMedView Article
  8. Brown JS, Vittinghoff E, Wyman JF, Stone KL, Nevitt MC, Ensrud KE, Grady D (2000) Urinary incontinence: does it increase risk for falls and fractures? Study of Osteoporotic Fractures Research Group. J.Am Geriatr Soc 48:721–725PubMed
  9. Brown JS, McGhan WF, Chokroverty S (2000) Comorbidities associated with overactive bladder. Am J Manag Care 6:S574–S579PubMed
  10. Bjelic-Radisic V, Dorfer M, Tamussino K, Greimel E (2005) Psychometric properties and validation of the German-language King’s Health Questionnaire in women with stress urinary incontinence. Neurourol Urodyn 24:63–68PubMedView Article
  11. Kelleher C (2000) Quality of life and urinary incontinence. Baillieres Best Pract Res Clin Obstet Gynaecol 14:363–379PubMedView Article
  12. Costa P, Perrouin-Verbe B, Colvez A, Didier J, Marquis P, Marrel A, Amarenco G, Espirac B, Leriche A (2001) Quality of life in spinal cord injury patients with urinary difficulties. Development and validation of Qualiveen. Eur Urol 39:107–113PubMedView Article
  13. Kelleher CJ, Cardozo LD, Khullar V, Salvatore S (1997) A new questionnaire to assess the quality of life of urinary incontinent women. Br J Obstet Gynaecol 104:1374–1379PubMedView Article
  14. Reese PR, Pleil AM, Okano GJ, Kelleher CJ (2003) Multinational study of reliability and validity of the King’s Health Questionnaire in patients with overactive bladder. Qual Life Res 12:427–442PubMedView Article
  15. Uemura S, Homma Y (2004) Reliability and validity of King’s Health Questionnaire in patients with symptoms of overactive bladder with urge incontinence in Japan. Neurourol Urodyn 23:94–100PubMedView Article
  16. Lenderking WR, Nackley JF, Anderson RB, Testa MA (1996) A review of the quality-of-life aspects of urinary urge incontinence. Pharmacoeconomics 9:11–23PubMedView Article
  17. Conway K, Uzun V, Marrel A, Cardozo L, Kelleher C, Haye I (1999) Linguistic validation of the King’s Health Questionnaire (KHQ) in eight languages (abstract). Value Health 2:204View Article
  18. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, Johnson KP, Sibley WA, Silberberg DH, Tourtellotte WW (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13:227–231PubMedView Article
  19. Vickrey BG, Hays RD, Harooni R, Myers LW, Ellison GW (1995) A health-related quality of life measure for multiple sclerosis. Qual Life Res 4:187–206PubMedView Article
  20. Idiman E, Uzunel F, Ozakbas S, Yozbatiran N, Oguz M, Callioglu B, Gokce N, Bahar Z (2006) Cross-cultural adaptation and validation of multiple sclerosis quality of life questionnaire (MSQoL-54) in a Turkish multiple sclerosis sample. J Neurol Sci 240:77–80PubMedView Article
  21. Kurtzke JF (2000) Natural history and clinical outcome measures for multiple sclerosis studies. Why at the present time does EDSS scale remain a preferred outcome measure to evaluate disease evolution? Neurol Sci 21:339–341PubMedView Article
  22. Kobelt G, Kirchberger I, Malone-Lee J (1999) Quality-of-life aspects of the overactive bladder and the effect of treatment with tolterodine. BJU Int 83:583–590PubMedView Article
Metadata
Title
Quality of life in multiple sclerosis patients with urinary disorders: reliability and validity of the Turkish version of King’s Health Questionnaire
Authors
Yeşim Akkoc
Hale Karapolat
Sibel Eyigor
Hilal Yesil
Nur Yüceyar
Publication date
01-06-2011
Publisher
Springer Milan
Published in
Neurological Sciences / Issue 3/2011
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-011-0484-9

Other articles of this Issue 3/2011

Neurological Sciences 3/2011 Go to the issue

Brief Communication

Association study between four polymorphisms in the HFE, TF and TFR genes and Parkinson’s disease in Southern Italy

Case Report

Reversible encephalopathy induced by cefoperazone: a case report monitored with EEG

Original Article

Cerebral microbleeds and quality of life in acute ischemic stroke

Original Article

Chronic acquired hepatocerebral degeneration: effects of liver transplantation on neurological manifestations

Case Report

A case of subarachnoid hemorrhage with pituitary apoplexy caused by idiopathic hypertrophic pachymeningitis

Case Report

Serotonin toxicity: a short review of the literature and two case reports involving Citalopram